Reported 2 days ago
Merck & Co., Inc. (MRK) stands out as a key value stock in billionaire investor Ken Fisher's portfolio, trading at a low forward P/E ratio of 8.49. Despite recent sell-offs caused by economic fears and tariffs, Fisher believes the market will rebound. With a significant equity stake of $1.60 billion and an optimistic outlook, particularly for its Animal Health division, Merck remains a strong investment choice amidst broader market concerns.
Source: YAHOO